RealFeedApp beta

One participant reached 15 months of disease control

In a University of Minnesota Phase I trial, an experimental genetically engineered adenovirus controlled disease for 15 months in one participant with inoperable pancreatic cancer.

Field
gene therapy
What they did
Researchers from the University of Minnesota conducted a Phase I clinical trial where three patients with inoperable pancreatic cancer received an injection of a genetically engineered adenovirus.
Why it matters
The virus enters and replicates within malignant cells, helping the immune system recognize and attack them, resulting in 15 months of disease control for one participant.
#adenovirus#pancreatic cancer#clinical trial#gene therapy

Read the original →